StockDrifts LogoStockDrifts

FCPM III Services B V 13F Portfolio

Portfolio Manager
Fcpm III Services B V
Performance
+6.65% (2026 Q2)
AUM (13F)
$750.41M
# of Holdings
11
Performance Rank
Allocation (Top 20)
99.99%
Latest filing
Q2 2026

Fcpm III Services B V Holdings Map

Top 11 Fcpm III Services B V Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
NAMS
NEWAMSTERDAM PHARMA COMPANY
38.34%8.49M$287.7M
-7.70%(-708.55K)
2025-Q2: 10.63M shares2025-Q3: 9.21M shares2025-Q4: 9.20M shares2026-Q1: 9.20M shares2026-Q2: 8.49M shares
$10.61(+151.41%)
2026-06-30
MPLT
MAPLIGHT THERAPEUTICS INC
15.41%3.23M$115.6M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 3.23M shares2026-Q1: 3.23M shares2026-Q2: 3.23M shares
$17.57(-34.07%)
2026-06-30
DYN
DYNE THERAPEUTICS INC
11.39%3.85M$85.5M
-17.14%(-796.13K)
2025-Q2: 5.46M shares2025-Q3: 5.46M shares2025-Q4: 5.46M shares2026-Q1: 4.64M shares2026-Q2: 3.85M shares
$13.25(+95.88%)
2026-06-30
VOR
VOR BIOPHARMA INC
10.1%4.12M$75.8M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 379.6K shares2025-Q4: 3.62M shares2026-Q1: 4.12M shares2026-Q2: 4.12M shares
$29.92(-22.15%)
2026-06-30
DMRA
DAMORA THERAPEUTICS INC
8.46%2.44M$63.5M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 2.44M shares2026-Q2: 2.44M shares
$24.45(+25.66%)
2026-06-30
REPL
REPLIMUNE GROUP INC
4.14%2.81M$31.1M
+0.00%(+0)
2025-Q2: 3.91M shares2025-Q3: 4.16M shares2025-Q4: 2.81M shares2026-Q1: 2.81M shares2026-Q2: 2.81M shares
$12.41(+22.41%)
2026-06-30
CBIO
CRESCENT BIOPHARMA INC.
4.02%1.68M$30.2M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.68M shares2026-Q1: 1.68M shares2026-Q2: 1.68M shares
$11.88(+40.04%)
2026-06-30
AURA
AURA BIOSCIENCES INC
3.84%4.05M$28.8Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 4.05M shares
$6.65(+15.04%)
2026-06-30
ENGN
ENGENE HOLDINGS INC
2.22%9.63M$16.7M
+0.00%(+0)
2025-Q2: 9.63M shares2025-Q3: 9.63M shares2025-Q4: 9.63M shares2026-Q1: 9.63M shares2026-Q2: 9.63M shares
$9.75(-82.67%)
2026-06-30
BCYC
BICYCLE THERAPEUTICS PLC
1.96%3.47M$14.7M
+0.00%(+0)
2025-Q2: 3.45M shares2025-Q3: 3.45M shares2025-Q4: 3.47M shares2026-Q1: 3.47M shares2026-Q2: 3.47M shares
$21.06(-81.11%)
2026-06-30

About Fcpm III Services B Vโ€™s portfolio

Fcpm III Services B V reports $750.41M in US-listed equity holdings across 11 positions in its most recent 13F filing. Its largest disclosed positions are NAMS (38.3%), MPLT (15.4%) and DYN (11.4%). The top 20 holdings account for 99.99% of reported assets. Its disclosed equity book has returned +89.47% cumulatively over 10 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
NAMS โ€” 38.3% ($287.74M)MPLT โ€” 15.4% ($115.63M)DYN โ€” 11.4% ($85.47M)VOR โ€” 10.1% ($75.80M)DMRA โ€” 8.5% ($63.49M)REPL โ€” 4.1% ($31.09M)CBIO โ€” 4.0% ($30.20M)AURA โ€” 3.8% ($28.78M)ENGN โ€” 2.2% ($16.66M)BCYC โ€” 2.0% ($14.71M)Other โ€” 0.1% ($834.4K)
100%in top 10
  • NAMS38.3%
  • MPLT15.4%
  • DYN11.4%
  • VOR10.1%
  • DMRA8.5%
  • REPL4.1%
  • CBIO4.0%
  • AURA3.8%
  • ENGN2.2%
  • BCYC2.0%
  • Other0.1%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
1
AURAAURA BIOSCIENCES INC3.8%
Trimmed
2
NAMSNEWAMSTERDAM PHARMA COMPANY-7.7%
DYNDYNE THERAPEUTICS INC-17.1%

Unlock alerts, watchlists & AI chat

Sign up free to track Fcpm III Services B V, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Fcpm III Services B Vโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2013410). View Fcpm III Services B Vโ€™s 13F filings on SEC

More 13F analyses

View all